GT Biopharma, Inc.

GTBP · NASDAQ
Analyze with AI
Filings24
Total reported value$274.9K
ManagerSharesValue
Change
DRW Securities, LLC142.4K$104.6K+50.0%
BANK OF MONTREAL /CAN/92.5K$68.0K0.0%
CITADEL ADVISORS LLC39.6K$29.1K+50.0%
GEODE CAPITAL MANAGEMENT, LLC24K$17.6K+0.5%
TWO SIGMA SECURITIES, LLC17.1K$12.5K+50.0%
MORGAN STANLEY14K$10.3K+41.6%
VANGUARD GROUP INC10.5K$7.7K0.0%
WELLS FARGO & COMPANY/MN10K$7.4K0.0%
BlackRock, Inc.9.7K$7.2K0.0%
ADVISOR GROUP HOLDINGS, INC.5.1K$3.7K+487.3%
Newbridge Financial Services Group, Inc.3.8K$2.8K+21.1%
UBS Group AG2.6K$1.9K+570.6%
Tower Research Capital LLC (TRC)1.7K$1.3K+42.4%
Clearstead Advisors, LLC865$635.50.0%
JONES FINANCIAL COMPANIES LLLP300$220.40.0%
BANK OF AMERICA CORP /DE/24$17.6-26.3%
BNP PARIBAS ARBITRAGE, SNC16$11.80.0%
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC10$7.30.0%
SBI Securities Co., Ltd.5$3.7-25.0%
JPMORGAN CHASE & CO1$0.70.0%
Allworth Financial LP1$0.70.0%
Mount Yale Investment Advisors, LLC0$0.0+100.0%
Front Row Advisors LLC0$0.0+100.0%
RENAISSANCE TECHNOLOGIES LLC0$0.0+100.0%